|
bioavailability |
7 |
|
cell cycle |
7 |
|
fecal enzyme |
7 |
|
gut microbiota |
7 |
|
humans |
7 |
|
l. rhamnosus |
7 |
|
proteomics |
7 |
|
soy isoflavone |
7 |
|
antineoplastic agents - pharmacology |
6 |
|
apoptosis |
6 |
|
carbon tetrachloride |
5 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology - secondary |
5 |
|
cell cycle - drug effects |
5 |
|
cyclooxygenase-2 |
5 |
|
docosahexaenoic acid |
5 |
|
docosahexaenoic acids - pharmacology |
5 |
|
flow cytometry |
5 |
|
hepatocellular carcinoma |
5 |
|
liver neoplasms - genetics - metabolism - pathology |
5 |
|
sugar |
5 |
|
ω-3 fatty acids |
5 |
|
adult |
4 |
|
asian |
4 |
|
body composition |
4 |
|
caucasian |
4 |
|
cell survival - drug effects |
4 |
|
coffee |
4 |
|
cytokines |
4 |
|
food intake |
4 |
|
glycemia |
4 |
|
hepatotoxicity |
4 |
|
hl-60 cells |
4 |
|
life expectancy |
4 |
|
lifelong |
4 |
|
lipid |
4 |
|
liver |
4 |
|
metabolic syndrome |
4 |
|
monocytes - drug effects - metabolism |
4 |
|
obesity |
4 |
|
reactive oxygen species |
4 |
|
animals |
3 |
|
apoptosis - drug effects - genetics |
3 |
|
ascomycota - chemistry |
3 |
|
basidiomycota - chemistry |
3 |
|
breezhaler™ |
3 |
|
bromodeoxyuridine |
3 |
|
cdna microarray |
3 |
|
cell proliferation - drug effects |
3 |
|
cells, cultured |
3 |
|
chronic obstructive pulmonary disease |
3 |
|
cytarabine |
3 |
|
cytokines - biosynthesis |
3 |
|
cytotoxicity |
3 |
|
doxorubicin |
3 |
|
ellipta™ |
3 |
|
enzyme-linked immunosorbent assay |
3 |
|
etoposide |
3 |
|
fungal compounds |
3 |
|
gene expression profiles |
3 |
|
gene expression regulation, neoplastic - drug effects - genetics |
3 |
|
genuair® |
3 |
|
immune mediated diseases |
3 |
|
immunoglobulin g - biosynthesis |
3 |
|
immunoglobulin m - biosynthesis |
3 |
|
immunologic factors - chemistry - pharmacology |
3 |
|
immunomodulation |
3 |
|
immunomodulatory drugs |
3 |
|
inhalation device |
3 |
|
lymphocyte culture test, mixed |
3 |
|
lymphocytes - drug effects |
3 |
|
male |
3 |
|
medicinal fungal compounds |
3 |
|
mitogens - metabolism |
3 |
|
necrotizing enterocolitis |
3 |
|
oligonucleotide array sequence analysis - methods |
3 |
|
oxidative stress |
3 |
|
pestalotiopsis leucothës |
3 |
|
phenotype |
3 |
|
polysaccharopeptide |
3 |
|
proteins and peptide bound polysaccharides |
3 |
|
proteoglycans - isolation and purification - pharmacology |
3 |
|
proteoglycans - pharmacology |
3 |
|
rats |
3 |
|
receptors, interleukin-2 - biosynthesis |
3 |
|
th1 cells - drug effects - metabolism |
3 |
|
th2 cells - drug effects - metabolism |
3 |
|
traditional chinese medicine |
3 |
|
tripterygium - microbiology |
3 |
|
tripterygium wilfordii |
3 |
|
2-de |
2 |
|
actin cytoskeleton |
2 |
|
adults |
2 |
|
alexandrium tamarense |
2 |
|
alpha-tocopherol - pharmacology |
2 |
|
antigens, cd4 - drug effects |
2 |
|
antigens, cd56 - drug effects |
2 |
|
antigens, cd8 - drug effects |
2 |
|
antioxidants - metabolism - pharmacology |
2 |
|
apoptosis - radiation effects |
2 |
|
biomarker |
2 |
|
biomarker of toxicity |
2 |
|
breast neoplasms - pathology |
2 |
|
capillary glucose |
2 |
|
carcinoma, ductal, breast - pathology |
2 |
|
cell body displacement |
2 |
|
cell body shrinkage |
2 |
|
cell cycle arrest |
2 |
|
cell cycle checkpoints - radiation effects |
2 |
|
cell differentiation - drug effects |
2 |
|
cell division |
2 |
|
cell division - drug effects |
2 |
|
cell line, tumor |
2 |
|
cell signaling |
2 |
|
cell-mediated immunity |
2 |
|
cellular stress |
2 |
|
characteristic time |
2 |
|
chinese medicinal mushroom |
2 |
|
ciclosporin |
2 |
|
coriolus versicolor |
2 |
|
corn oil |
2 |
|
cyclosporine a |
2 |
|
cytomechanics |
2 |
|
cytoplasmmic signals |
2 |
|
danshen |
2 |
|
decaffeinated coffee |
2 |
|
deoxynivalenol |
2 |
|
dietary fats - pharmacology |
2 |
|
dna synthesis delay |
2 |
|
doxorubicin - pharmacology |
2 |
|
drug synergism |
2 |
|
electroporation - methods |
2 |
|
endothelium, vascular - metabolism |
2 |
|
enteral formula feeding |
2 |
|
etoposide - pharmacology |
2 |
|
f-actin disassembly |
2 |
|
fatty acids, omega-3 - pharmacology |
2 |
|
female |
2 |
|
fish oils - pharmacology |
2 |
|
flash glucose monitoring system |
2 |
|
flow cytometer |
2 |
|
free radicals |
2 |
|
fumonisin b1 |
2 |
|
g-actin accumulation |
2 |
|
germ free |
2 |
|
glomerulus |
2 |
|
glutathione |
2 |
|
glutathione - metabolism |
2 |
|
harmful algal bloom species |
2 |
|
heymann nephritis |
2 |
|
high performance liquid chromatography |
2 |
|
high-energy shock waves |
2 |
|
human breast cancer |
2 |
|
human lymphocyte proliferation |
2 |
|
human t lymphocytes |
2 |
|
hydrogen peroxide |
2 |
|
hydrogen peroxide - metabolism |
2 |
|
immunity |
2 |
|
interstitial glucose |
2 |
|
intestinal epithelia |
2 |
|
kidney |
2 |
|
lactic acid |
2 |
|
lard |
2 |
|
leucine - metabolism |
2 |
|
leukemia, promyelocytic, acute - pathology - physiopathology |
2 |
|
lipid accumulation |
2 |
|
lipopolysaccharides - toxicity |
2 |
|
liver fibrosis |
2 |
|
low-intensity ultrasound |
2 |
|
lps |
2 |
|
lymphocyte |
2 |
|
lymphocyte subsets - drug effects |
2 |
|
lymphocytes - drug effects - immunology |
2 |
|
mass spectrometry |
2 |
|
mechanotransduction |
2 |
|
membrane |
2 |
|
membrane perforation |
2 |
|
membrane recovery |
2 |
|
membrane shrinkage |
2 |
|
microbial colonization |
2 |
|
milk |
2 |
|
mitochondrial membrane potential |
2 |
|
mitogens - toxicity |
2 |
|
mitosis |
2 |
|
molt 4 leukemia |
2 |
|
neurite retraction |
2 |
|
neuronal development |
2 |
|
nivalenol |
2 |
|
nucleus |
2 |
|
paralytic shellfish poisoning toxin |
2 |
|
pathophysiology |
2 |
|
peripheral blood mononuclear cells |
2 |
|
phytohemagglutinins - toxicity |
2 |
|
polyclonal antibodies |
2 |
|
postprandial glucose |
2 |
|
postprandial insulin |
2 |
|
premature neonates |
2 |
|
pro-inflammatory cytokines |
2 |
|
proteoglycan |
2 |
|
proteome |
2 |
|
radiation dosage |
2 |
|
rats, inbred strains |
2 |
|
rats, sprague-dawley |
2 |
|
real-time confocal imaging |
2 |
|
real-time imaging |
2 |
|
receptors, interleukin-2 - drug effects |
2 |
|
repulsive cue |
2 |
|
salvia miltiorrhiza |
2 |
|
selenium |
2 |
|
selenium - pharmacology |
2 |
|
single-site sonoporation |
2 |
|
sonication |
2 |
|
sonoporation |
2 |
|
spatiotemporal dynamics |
2 |
|
structure tensor analysis |
2 |
|
temporal study |
2 |
|
time factors |
2 |
|
tnf |
2 |
|
tumor growth |
2 |
|
two dimensional gel electrophoresis |
2 |
|
two-dimensional gel electrophoresis |
2 |
|
ultrasound |
2 |
|
urine |
2 |
|
vitamin e |
2 |
|
wave-cell interaction |
2 |
|
zearalenone |
2 |
|
2d-dige |
1 |
|
9,10-dimethyl-1,2-benzanthracene |
1 |
|
acas570 |
1 |
|
acute renal failure |
1 |
|
adenine |
1 |
|
adenocarcinoma - blood supply - chemically induced - metabolism - pathology |
1 |
|
alexandrium minutum |
1 |
|
amino acids - physiology |
1 |
|
analysis of variance |
1 |
|
antibiotics, antineoplastic - pharmacology |
1 |
|
antioxidation |
1 |
|
apoptosis - drug effects |
1 |
|
arteriosclerosis - metabolism |
1 |
|
atherosclerosis |
1 |
|
bcl-2 |
1 |
|
bcl-2 and bax |
1 |
|
binding, competitive |
1 |
|
blood pressure |
1 |
|
body temperature - genetics |
1 |
|
body weight |
1 |
|
brdurd |
1 |
|
bromodeoxyuridine - diagnostic use - metabolism - pharmacokinetics |
1 |
|
bromodeoxyuridine - metabolism |
1 |
|
bromodeoxyuridine - pharmacokinetics |
1 |
|
burns - metabolism |
1 |
|
calorimetry, indirect |
1 |
|
carbon radioisotopes |
1 |
|
carcinoma 256, walker - chemistry - metabolism - pathology |
1 |
|
carcinoma 256, walker - pathology |
1 |
|
carcinosarcoma - metabolism - pathology |
1 |
|
cardiac output - drug effects |
1 |
|
caspase |
1 |
|
cell culture techniques |
1 |
|
cell cycle - physiology |
1 |
|
cell cycle distribution |
1 |
|
cell line |
1 |
|
cell transformation, neoplastic - metabolism - pathology |
1 |
|
cellular proliferation |
1 |
|
chinese herb preparation |
1 |
|
cholesterol - metabolism |
1 |
|
chronic renal failure |
1 |
|
cocos |
1 |
|
copper |
1 |
|
cordyceps sinensis |
1 |
|
corn oil - pharmacology |
1 |
|
coronary heart disease |
1 |
|
culture media, conditioned |
1 |
|
diet - adverse effects |
1 |
|
dietary fats - administration & dosage |
1 |
|
dietary fats - adverse effects |
1 |
|
dna - analysis - metabolism |
1 |
|
dna - biosynthesis |
1 |
|
dna fragmentation - drug effects |
1 |
|
dna ladder |
1 |
|
dna synthesis time |
1 |
|
dna, neoplasm - metabolism |
1 |
|
doubling time |
1 |
|
down-regulation |
1 |
|
drug screening assays, antitumor |
1 |
|
eicosanoids - physiology |
1 |
|
eicosapentaenoic acid |
1 |
|
eicosapentaenoic acid - pharmacology |
1 |
|
endotoxin |
1 |
|
endotoxins - antagonists & inhibitors - pharmacology |
1 |
|
endotoxins - toxicity |
1 |
|
energy intake |
1 |
|
energy metabolism |
1 |
|
energy metabolism - genetics |
1 |
|
enteral nutrition |
1 |
|
environmental stress |
1 |
|
escherichia coli |
1 |
|
extracellular signal-regulated map kinases - genetics - metabolism |
1 |
|
family health |
1 |
|
fasting |
1 |
|
fat emulsions, intravenous - metabolism - therapeutic use |
1 |
|
fatty acids - analysis |
1 |
|
fatty acids - blood - pharmacology |
1 |
|
fatty acids, nonesterified - blood |
1 |
|
fatty acids, omega-6 |
1 |
|
fatty acids, unsaturated - metabolism |
1 |
|
fatty acids, unsaturated - pharmacology |
1 |
|
fish oil |
1 |
|
fish oils - administration & dosage |
1 |
|
flow cytometry - methods |
1 |
|
floxuridine - diagnostic use |
1 |
|
g0 phase - drug effects |
1 |
|
g1 phase - drug effects |
1 |
|
g1 phase - physiology |
1 |
|
g2 phase - physiology |
1 |
|
gene expression regulation, enzymologic - drug effects |
1 |
|
genotype |
1 |
|
glomeruli |
1 |
|
glucose - metabolism |
1 |
|
glutathione peroxidase |
1 |
|
glutathione peroxidase - drug effects - genetics - metabolism |
1 |
|
glutathione transferase |
1 |
|
glycerol |
1 |
|
growth phases |
1 |
|
guinea pigs |
1 |
|
haptoglobin |
1 |
|
harmful algal bloom (hab) species |
1 |
|
human leukemic cells |
1 |
|
immune modulator |
1 |
|
immune system diseases - drug therapy - metabolism |
1 |
|
immune tolerance |
1 |
|
immunologic factors - pharmacology |
1 |
|
infection - drug therapy - metabolism |
1 |
|
inflammation - complications - immunology |
1 |
|
insulin-like growth factor |
1 |
|
insulin-like growth factor i - pharmacology |
1 |
|
interferon-γ |
1 |
|
interleukin-1 - biosynthesis |
1 |
|
j774 cell line |
1 |
|
j774.a1 |
1 |
|
kidney diseases - genetics |
1 |
|
kidney diseases - metabolism |
1 |
|
kidney-yang deficiency syndrome (kds) |
1 |
|
kinetics |
1 |
|
kreskin |
1 |
|
krestin |
1 |
|
l929 cell-conditioned medium |
1 |
|
lactates - blood |
1 |
|
lactates - metabolism |
1 |
|
leukemia |
1 |
|
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy - pathology |
1 |
|
leukemia, promyelocytic, acute - drug therapy - pathology |
1 |
|
linkage disequilibrium |
1 |
|
linkage disequilibrium (ld) |
1 |
|
linoleic acid |
1 |
|
linoleic acid - metabolism |
1 |
|
linoleic acids - administration & dosage |
1 |
|
lipid hydroperoxide |
1 |
|
lipid peroxidation |
1 |
|
lipids - chemistry - pharmacology |
1 |
|
lipoperoxidative injury |
1 |
|
lipopolysaccharide |
1 |
|
lipopolysaccharides - pharmacology |
1 |
|
lipoproteins, ldl |
1 |
|
lipoproteins, ldl - chemistry |
1 |
|
lipoproteins, ldl - metabolism |
1 |
|
lipoproteins, ldl - physiology - toxicity |
1 |
|
liver - drug effects - metabolism |
1 |
|
liver - metabolism - physiopathology |
1 |
|
liver and muscle protein |
1 |
|
low-density lipoprotein |
1 |
|
macrophage |
1 |
|
macrophage colony-stimulating factor |
1 |
|
macrophage colony-stimulating factor - pharmacology |
1 |
|
macrophages |
1 |
|
macrophages - drug effects - metabolism |
1 |
|
macrophages, peritoneal - cytology - drug effects - metabolism |
1 |
|
macrophages, peritoneal - drug effects - enzymology |
1 |
|
macrophages, peritoneal - metabolism |
1 |
|
malondialdehyde |
1 |
|
malondialdehyde - metabolism |
1 |
|
malondialdehyde modification |
1 |
|
malondialdelhyde modification |
1 |
|
mammary neoplasms, experimental - blood supply - metabolism - pathology |
1 |
|
manganese superoxide dismutase |
1 |
|
map kinase signaling system - genetics - physiology |
1 |
|
mathematics |
1 |
|
medicine, chinese traditional |
1 |
|
membrane fluidity - drug effects |
1 |
|
membranous nephropathy |
1 |
|
mice |
1 |
|
models, biological |
1 |
|
monoclonal antibody |
1 |
|
multiple organ failure - metabolism - physiopathology - therapy |
1 |
|
muscle proteins - metabolism |
1 |
|
muscles - blood supply - drug effects - metabolism |
1 |
|
neoplasm proteins - metabolism |
1 |
|
neoplasm transplantation |
1 |
|
neoplasms - metabolism - pathology |
1 |
|
neoplasms, experimental - pathology |
1 |
|
nitric oxide |
1 |
|
nitric oxide - biosynthesis |
1 |
|
nitric oxide synthase |
1 |
|
nitrogen - metabolism |
1 |
|
non-selenium dependent glutathione peroxidase |
1 |
|
nutritional physiological phenomena |
1 |
|
nutritional requirements |
1 |
|
oxidation-reduction |
1 |
|
oxidative modification |
1 |
|
oxidative stress - drug effects |
1 |
|
oxidatively modified low-density lipoprotein |
1 |
|
oxidised low density lipoprotein |
1 |
|
oxidised low-density lipoprotein |
1 |
|
oxidized cholesterol |
1 |
|
oxidized ldl |
1 |
|
paralytic shellfish poisoning |
1 |
|
parenteral nutrition |
1 |
|
parenteral nutrition, total |
1 |
|
parenteral nutrition, total - adverse effects |
1 |
|
passive heymann nephritis |
1 |
|
pedigree |
1 |
|
peritoneal macrophage |
1 |
|
peritoneal neoplasms - metabolism - pathology |
1 |
|
phosphatidylcholines - metabolism |
1 |
|
phospholipids - blood |
1 |
|
plaque |
1 |
|
polymorphism, single nucleotide |
1 |
|
polysaccharide |
1 |
|
polysaccharide krestin |
1 |
|
polysaccharide krestin (psk) |
1 |
|
polysaccharide peptide |
1 |
|
polysaccharides, protein-bound |
1 |
|
preprohaptoglobin |
1 |
|
preterm neonate |
1 |
|
propidium - diagnostic use |
1 |
|
protein breakdown |
1 |
|
protein synthesis |
1 |
|
protein-energy malnutrition - complications - immunology |
1 |
|
proteins - metabolism |
1 |
|
proto-oncogene proteins c-bcl-2 - biosynthesis |
1 |
|
radioisotope dilution technique |
1 |
|
random allocation |
1 |
|
rats, inbred f344 |
1 |
|
receptors, ldl |
1 |
|
recombinant proteins - pharmacology |
1 |
|
regional blood flow |
1 |
|
rheum palmatum |
1 |
|
rna, messenger - genetics |
1 |
|
s phase - physiology |
1 |
|
safflower oil - pharmacology |
1 |
|
selenium dependent glutathione peroxidase |
1 |
|
shock, septic - metabolism - physiopathology |
1 |
|
single nucleotide polymorphism (snp) |
1 |
|
spectrometry, fluorescence |
1 |
|
splanchnic circulation - drug effects |
1 |
|
term neonate |
1 |
|
tert-butyl hydroperoxide |
1 |
|
tert-butylhydroperoxide - toxicity |
1 |
|
thiobarbituric acid reactive substances - metabolism |
1 |
|
thromboxane a2 - physiology |
1 |
|
toxemia - physiopathology |
1 |
|
trace elements - physiology |
1 |
|
traditional chinese medicine (tcm) |
1 |
|
triglycerides - administration & dosage - blood - chemistry |
1 |
|
tumor cell-cycle proliferation |
1 |
|
tumor cells, cultured |
1 |
|
tumor cells, cultured - chemistry - metabolism - pathology |
1 |
|
tumor necrosis factor-alpha - pharmacology |
1 |
|
tumor promotion |
1 |
|
u937 cell line |
1 |
|
wh30+ |
1 |
|
yang deficiency - genetics |
1 |
|
zinc |
1 |
